M. Childs

发表

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

Enno Schmidt, Diane Whitham, N J Levell, 2017, The Lancet.

Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies.

B. Morland, G. Perilongo, R. Kebudi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.

G. Perilongo, A. Zimmermann, L. Brugières, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

I. Ellis, L. Fallowfield, G. Mann, 2021, BMJ Open.

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

B. Morland, G. Perilongo, A. Zimmermann, 2013, The Lancet. Oncology.

A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.

H. Williams, D. Whitham, F. Wojnarowska, 2017, Health technology assessment.

(2015). Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial. Trials

C. Rogers, L. Culliford, M. Childs, 2015 .

I. Ellis, L. Fallowfield, G. Mann, 2021, BMJ Open.

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.

B. Morland, G. Perilongo, A. Zimmermann, 2009, The New England journal of medicine.

2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group

K. McHugh, G. Perilongo, Ø. Olsen, 2006, Pediatric Radiology.

Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer.

Yu Wei, Jean-François Michiels, Giuseppe Basso, 2008, Cancer cell.

Potential biomarkers for hepatoblastoma: results from the SIOPEL-3 study.

A. Zimmermann, R. Purcell, M. Childs, 2012, European journal of cancer.

2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group

K. McHugh, G. Perilongo, Ø. Olsen, 2007, Pediatric radiology.

Place and provision of palliative care for children with progressive cancer: a study by the Paediatric Oncology Nurses' Forum/United Kingdom Children's Cancer Study Group Palliative Care Working Group.

G. Collins, A. Thompson, R. Hain, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sodium Thiosulfate for Protection from Cisplatin‐Induced Hearing Loss

B. Morland, E. Hiyama, G. Perilongo, 2018, The New England journal of medicine.

Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost‐effectiveness analysis of the BLISTER trial

D. Whitham, J. Mason, F. Wojnarowska, 2018, The British journal of dermatology.

Rachel Purcell, A. Zimmermann, R. Purcell, 2011, Journal of experimental & clinical cancer research : CR.

Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.

G. Perilongo, L. Brugières, R. Rondelli, 2004, European journal of cancer.

Symptoms in Children/Young People With Progressive Malignant Disease: United Kingdom Children's Cancer Study Group/Paediatric Oncology Nurses Forum Survey

G. Collins, A. Goldman, R. Hain, 2006, Pediatrics.

Opioid use in palliative care of children and young people with cancer.

G. Collins, A. Goldman, R. Hain, 2008, The Journal of pediatrics.

Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group

B. Morland, R. Alaggio, G. Perilongo, 2018, Pediatric blood & cancer.

Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).

G. Perilongo, A. Zimmermann, C. Domerg, 2013, European journal of cancer.

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

B. Morland, G. Perilongo, A. Zimmermann, 2012, European journal of cancer.

Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group.

G. Perilongo, L. Brugières, P. Brock, 2004, European journal of cancer.

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.

G. Perilongo, A. Zimmermann, L. Brugières, 2013, European journal of cancer.

Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial

A. Montgomery, L. Duley, W. Tan, 2016, Trials.

Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial

A. Foss, A. Montgomery, W. Tan, 2015, Trials.

TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands

A. Foss, A. Montgomery, L. Duley, 2020, BMJ open ophthalmology.

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

B. Morland, G. Perilongo, A. Zimmermann, 2012, European journal of cancer.

Computational drug prediction in hepatoblastoma by integrating pan-cancer transcriptomics with pharmacological response

S. Cairo, C. Armengol, M. Childs, 2023, Hepatology.